Research on Voice Intelligent Monitoring Technology for Early Warning of Recurrence of Depression Disorder
1 other identifier
observational
240
1 country
1
Brief Summary
This study aims to collect the voice output of depression patients and healthy subjects, extract the acoustic and semantic parameters, compare the similarities and differences between the depression group and the healthy control group horizontally, and track the depression patients' changes in the rehabilitation stage to construct a voice-based early warning model of depression recurrence. At the same time, the use of EEG technology, nuclear magnetic resonance and near-infrared brain imaging technology to record and analyze the neural activity characteristics behind the voice variation of depression patients, and build a neural mechanism model. And construct the facial recognition function through the convolutional neural network, extract the facial parameters to enrich the intelligent monitoring and early warning technology.
- 1.Collect linguistic data of depression patients and healthy people collected in the laboratory, as well as data related to changes in the condition of depression patients in daily life and home care after treatment, and construct comparative data and dynamic observations Large database to analyze its voice mutation characteristics;
- 2.Using EEG technology, nuclear magnetic resonance, and near-infrared brain imaging to record and analyze the neural activity characteristics behind the voice variation of depression patients, and build a neural mechanism model.
- 3.Use the convolutional neural network to realize the facial recognition function, and extract the facial parameters to enrich the monitoring indicators.
- 4.Based on the dynamic observation big data of depression speech mutation, construct the speech feature parameter vector of depression recurrence, and use adaptive personalized intelligent learning algorithm to develop intelligent monitoring and early warning technology.
- 5.Establish monitoring and diagnostic indicators for recurrence early warning, verify the application of the above-mentioned intelligent monitoring and early warning technology in rehabilitation guidance, and make a comprehensive assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2020
CompletedFirst Posted
Study publicly available on registry
December 28, 2020
CompletedStudy Start
First participant enrolled
December 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedMay 19, 2021
November 1, 2020
1 year
November 18, 2020
May 17, 2021
Conditions
Outcome Measures
Primary Outcomes (5)
Acoustic parameters
Acoustic parameters of depression patients and healthy subjects are extracted through voice recording.
2022.6
Neural activity parameters of EEG
Neural activity parameters of depression patients and healthy subjects are extracted through EEG technology.
2022.6
Neural activity parameters of MRI
Neural activity parameters of depression patients and healthy subjects are extracted through MRI.
2022.6
Neural activity parameters of near-infrared brain imaging
Neural activity parameters of depression patients and healthy subjects are extracted through near-infrared brain imaging.
2022.6
Facial action parameters of facial expression recognition technology
The facial expression recognition technology is implemented by convolutional neural network to extract facial action parameters.
2022.6
Study Arms (3)
Patients with Depression in consolidation phase
Patients with Depression in acute onset
Healthy subjects
Eligibility Criteria
It is planned to collect 80 patients with depression in the consolidating stage, 80 patients with depression in the acute stage, and 80 healthy controls recruited by advertisement in the psychological consultation clinic and psychiatric clinic of Shanghai Mental Health Center.
You may qualify if:
- Patients with depression in the consolidation/maintenance phase
- years old, no gender limit;
- Meet the DSM-5 diagnostic criteria for depression;
- Currently in the consolidation/maintenance phase, with stable condition, HAMD-17 \<7 points;
- Patients and their guardians understand the nature of this study and sign an informed consent form.
- Have sufficient audiovisual level to complete the necessary inspections for research;
- Han nationality
- Willing to participate in this research;
- Education level is junior high school and above.
- Patients with depression in acute onset:
- years old, no gender limit;
- Meet the DSM-5 diagnostic criteria for depression;
- Currently in depressive episode, HAMD-17\>17 points;
- Patients and their guardians understand the nature of this study and sign an informed consent form.
- Have sufficient audiovisual level to complete the necessary inspections for research;
- +10 more criteria
You may not qualify if:
- Patients with depression in the consolidation/maintenance phase
- Patients with severe brain diseases and other severe physical diseases;
- Diagnosis of other mental diseases such as schizophrenia and bipolar disorder;
- There are negative beliefs or a higher risk of suicide;
- People who are addicted to psychoactive substances such as alcohol or drugs;
- Women who are pregnant or about to become pregnant recently, and women who are breastfeeding;
- There are metal implants in the body: there is a pacemaker, intracranial silver clip, metal denture, arterial stent, arterial clip, joint metal fixation, or other metal implant conditions, or non-right-handed (this standard (Only for MRI testers);
- Failure to sign or refuse to sign the informed consent form.
- Patients with depression in acute onset:
- Patients with severe brain diseases and other severe physical diseases;
- Diagnosis of other mental diseases such as schizophrenia and bipolar disorder;
- There are negative beliefs or a higher risk of suicide;
- People who are addicted to psychoactive substances such as alcohol or drugs;
- Women who are pregnant or about to become pregnant recently, and women who are breastfeeding;
- There are metal implants in the body: there is a pacemaker, intracranial silver clip, metal denture, arterial stent, arterial clip, joint metal fixation, or other metal implant conditions, or non-right-handed (this standard (Only for MRI testers);
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2020
First Posted
December 28, 2020
Study Start
December 31, 2020
Primary Completion
December 31, 2021
Study Completion
December 31, 2022
Last Updated
May 19, 2021
Record last verified: 2020-11